Chi-Med Reports 2019 Full Year Results and Provides Updates on Key Clinical Programs
Stockwatch,
Chi-Med Reports 2019 Full Year Results and Provides Updates on Key Clinical Programs Company to Host Annual Results Conference…
Chi-Med Reports 2019 Full Year Results and Provides Updates on Key Clinical Programs Company to Host Annual Results Conference…
/EIN News/ -- Company to Host Annual Results Conference Call Today at 1:00 p.m.
Company to Host Annual Results Conference Call Today at 1:00 p.m. GMT / 8:00 a.m.
(GLOBE NEWSWIRE) -- Hutchison China MediTech Limited ("Chi-Med") (Nasdaq/AIM HCM), a commercial-stage biopharmaceutical company…
Company to Host Annual Results Conference Call Today at 1:00 p.m. GMT / 8:00 a.m.
Company to Host Annual Results Conference Call Today at 1:00 p.m. GMT / 8:00 a.m.
Hutchison China Meditech Limited 03 March 2020 Chi-Med Reports 2019 Full Year Results and Provides Updates on Key Clinical…
Company to Host Annual Results Conference Call Today at 1:00 p.m. GMT / 8:00 a.m.
LONDON, Oct. 17, 2019 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today highlighted the…
LONDON, Oct. 17, 2019 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today highlighted the…
Chi-Med highlights publication of Phase II data showing promising efficacy for Savolitinib in MET-amplified gastric cancers…
LONDON, Oct. 17, 2019 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today highlighted the…
LONDON, Oct. 17, 2019 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today highlighted the…
LONDON, Oct. 17, 2019 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited ("Chi-Med") (NASDAQ:HCM) today highlighted the…